We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
A four-day stay dedicated to your skin at a smart wellness destination in the capital’s greenbelt
Pharma group behind blockbuster drug wants to supersize its market impact
The Swiss pharma group needs to settle investor jitters with its latest acquisition
Adjustments for symptoms could benefit the wider workforce if fewer older women quit jobs
Steady shift towards outsourcing hip, knee and eye treatment expected to expand to other procedures despite concerns
Some high-achieving female workers still drink to prove themselves, but those going sober have found benefits
‘Treasure trove’ will be used to develop drugs and treatments for wide range of diseases and is culmination of 20 years of work
Non-profit offers $101mn for discoveries that will restore muscle, brain and immune functions
Diagnostic testing flags up a huge range of issues — both lifestyle and hereditary. So, what do you want to know?
Charlie McCormick, Aurora James, Antwaun Sargent and more share their holiday plans and present ideas for the season
Cancer Research UK report says UK government must invest in staffing and funding for research
No evidence to support ‘popular ideas that certain groups are more at risk’, according to researchers
Innovative models can drive funding for research on neglected, less survivable diseases
Turkey’s exports to Russia of goods vital for Moscow’s war machine have soared this year
Danish pharma group in talks with healthcare providers about innovative models to boost Wegovy take-up
Demand is soaring thanks to the NHS crisis, but providers are up against inflation and fierce competition for doctors
Bill Anderson says group is generating a series of promising new drugs after R&D strategy change
Health body’s concern reflects heightened vigilance over signs of disease outbreaks since Covid pandemic
Vaccine recipient claims he suffered side effect of severe blood clot
Claimants previously assessed as too sick for a job worried they could be told to work from home
German group says prospective blockbuster asundexian failed to demonstrate efficacy
Also in this newsletter: Why tourists and residents are fighting over Rome’s sidewalks
A new crop of weight-loss drugs is disrupting markets as well as transforming waistlines
In any conflict situation, from Gaza to Ukraine, medical staff must be protected and given unhindered access to patients
Royal College of GPs urges government to take action over ‘unsafe’ infrastructure ahead of Autumn Statement
International Edition
